Alzheimer's detection advances: blood biomarkers, VR cognitive tools

On World Alzheimer's Day, experts highlight new blood-based biomarkers enabling earlier detection and therapies that delay progression. In Argentina, virtual reality is being deployed to improve cognitive assessment. The shift signals a move toward earlier, more accessible diagnosis, though clinical adoption and validation remain ongoing.